Zimvie Inc (ZIMV) Stock Price, Quote & News

Latest News on ZIMV

Feb 26, 2025, 7:52 PM EST - 10 days ago

ZimVie Inc. (ZIMV) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 4:05 PM EST - 10 days ago

ZimVie Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 12, 2025, 4:05 PM EST - 24 days ago

ZimVie to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025

Jan 30, 2025, 8:00 AM EST - 5 weeks ago

ZimVie Announces Publication of a Study Supporting the Benefits of Its Implant Surface Technologies

Oct 30, 2024, 7:58 PM EDT - 4 months ago

ZimVie Inc. (ZIMV) Q3 2024 Earnings Call Transcript

Oct 16, 2024, 4:05 PM EDT - 5 months ago

ZimVie to Report Third Quarter Financial Results on October 30, 2024

Aug 4, 2024, 10:53 AM EDT - 7 months ago

ZimVie Inc. (ZIMV) Q2 2024 Earnings Call Transcript

Jul 23, 2024, 8:00 AM EDT - 8 months ago

ZimVie Announces FDA Clearance and U.S. Launch of GenTek® Restorative Components

Jul 18, 2024, 4:05 PM EDT - 8 months ago

ZimVie to Report Second Quarter Financial Results on August 1, 2024

May 16, 2024, 4:05 PM EDT - 10 months ago

ZimVie to Participate in Upcoming Investor Conferences

May 11, 2024, 6:07 AM EDT - 10 months ago

ZimVie Inc. (ZIMV) Q1 2024 Earnings Call Transcript

Apr 24, 2024, 4:05 PM EDT - 11 months ago

ZimVie to Report First Quarter Financial Results on May 8, 2024

Apr 1, 2024, 8:00 AM EDT - 1 year ago

H.I.G. Capital Acquires the Spine Business of ZimVie Rebranded as Highridge Medical

Apr 1, 2024, 8:00 AM EDT - 1 year ago

ZimVie Announces Closing of Sale of Spine Business

Mar 27, 2024, 8:00 AM EDT - 1 year ago

ZimVie to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Feb 28, 2024, 9:52 PM EST - 1 year ago

ZimVie Inc. (ZIMV) Q4 2023 Earnings Call Transcript

Feb 21, 2024, 5:00 PM EST - 1 year ago

ZimVie to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024

Feb 7, 2024, 4:05 PM EST - 1 year ago

ZimVie Announces Launch of Next-Generation TSX® Implant in Japan

Dec 26, 2023, 7:21 PM EST - 1 year ago

ZimVie: Focusing On Higher Growth Dental Business (Rating Upgrade)

Nov 1, 2023, 9:57 PM EDT - 1 year ago

ZimVie Inc. (ZIMV) Q3 2023 Earnings Call Transcript

Oct 31, 2023, 8:00 AM EDT - 1 year ago

ZimVie Announces First U.S. Surgery with the 4.5mm Mobi-C® Cervical Disc

Oct 17, 2023, 8:30 AM EDT - 1 year ago

ZimVie Announces the Launch of Azure™ Multi-Platform Product Solutions

Oct 11, 2023, 4:05 PM EDT - 1 year ago

ZimVie to Report Third Quarter 2023 Financial Results on November 1, 2023

Oct 10, 2023, 8:30 AM EDT - 1 year ago

ZimVie Announces the Recent Launch of Biotivity™ A/C Plus Membrane

Sep 26, 2023, 8:00 AM EDT - 1 year ago

ZimVie Announces FDA Approval to Launch Mobi-C® Hybrid Study

Aug 17, 2023, 8:00 AM EDT - 1 year ago

ZimVie Expands Development Cooperation Agreement with Brainlab AG to Include Co-Marketing

Aug 6, 2023, 2:21 AM EDT - 1 year ago

ZimVie Inc. (ZIMV) Q2 2023 Earnings Call Transcript

Aug 2, 2023, 4:05 PM EDT - 1 year ago

ZimVie Reports Second Quarter 2023 Financial Results and Provides Update to Annual Guidance

Jul 12, 2023, 4:05 PM EDT - 1 year ago

ZimVie to Report Second Quarter 2023 Financial Results on August 2, 2023

Jun 21, 2023, 12:15 AM EDT - 1 year ago

ZimVie: Downgrade To A Hold On Valuation And Fundamentals

May 22, 2023, 4:05 PM EDT - 1 year ago

ZimVie to Present at the Stifel 2023 Jaws & Paws Conference

May 4, 2023, 11:51 AM EDT - 2 years ago

ZimVie Inc. (ZIMV) Q1 2023 Earnings Call Transcript

Apr 13, 2023, 8:30 AM EDT - 2 years ago

ZimVie Announces the Recent Launches of RegenerOss® CC Allograft Particulate and RegenerOss® Bone Graft Plug

Apr 12, 2023, 4:10 PM EDT - 2 years ago

ZimVie to Report First Quarter 2023 Financial Results on May 3, 2023

Apr 3, 2023, 9:00 AM EDT - 2 years ago

ZimVie Announces Expanded Reimbursement and Exemplary Clinical Rating for Mobi-C®

Mar 23, 2023, 8:30 AM EDT - 2 years ago

ZimVie's Exclusive Puros® Cancellous Particulate Allograft Dental Bone Grafting Solution Excels in Landmark Comparative Study in The International Journal of Oral & Maxillofacial Implants

Mar 15, 2023, 8:30 AM EDT - 2 years ago

ZimVie Announces Additional Positive Policy Decisions for Vertebral Body Tethering

Mar 1, 2023, 7:47 PM EST - 2 years ago

ZimVie Inc. (ZIMV) Q4 2022 Earnings Call Transcript

Mar 1, 2023, 4:05 PM EST - 2 years ago

ZimVie Reports Fourth Quarter and Full Year 2022 Financial Results

Feb 23, 2023, 8:30 AM EST - 2 years ago

ZimVie Announces Launch of the RealGUIDE™ CAD and FULL SUITE Software Modules

Feb 13, 2023, 4:10 PM EST - 2 years ago

ZimVie to Report Fourth Quarter and Full Year 2022 Financial Results on March 1, 2023

Jan 30, 2023, 4:10 PM EST - 2 years ago

ZimVie Announces Over 200,000 Cervical Discs Have Been Replaced with Mobi-C®

Dec 28, 2022, 9:00 AM EST - 2 years ago

ZimVie to Present at the 41st Annual J.P. Morgan Healthcare Conference

Nov 12, 2022, 5:03 PM EST - 2 years ago

ZimVie Inc. (ZIMV) Q3 2022 Earnings Call Transcript

Nov 3, 2022, 8:30 AM EDT - 2 years ago

ZimVie Announces Launch of Next-Generation TSX™ Implant in the United States

Oct 19, 2022, 4:10 PM EDT - 2 years ago

ZimVie to Report Third Quarter 2022 Financial Results on November 9, 2022

Oct 11, 2022, 9:00 AM EDT - 2 years ago

ZimVie Expands Navigation-Compatible Platform to Include Posterior Cervical Application

Aug 29, 2022, 4:10 PM EDT - 2 years ago

ZimVie to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

Aug 25, 2022, 6:08 PM EDT - 2 years ago

ZimVie: Disappointing Guidance Prompts Caution

Aug 11, 2022, 1:35 AM EDT - 2 years ago

Market Cap	354.27M
Revenue (ttm)	449.75M
Net Income (ttm)	-25.83M
EPS (ttm)	N/A
PE Ratio	22.25
Forward PE	15.26
Profit Margin	-5.74%
Debt to Equity Ratio	0.58

Volume	293,000
Avg Vol	116,582
Day's Range	N/A - N/A
Shares Out	27.68M
Stochastic %K	19%
Beta	2.10
Analysts	Hold
Price Target	$19.00